......sounds like Zertane deal is basically done, and that there may be more than one partner for the drug, based on worldwide geographic territory. Don't know what happened to Dr. Bar-Or, but in my opinion it was a good thing he didn't present, as Dr. Vaughn was very well spoken & concise. The company sounds very confident about the ongoing trials. Please tell me, why is this a $4.00 stock? Should be more like $14.00 at this stage.
Yes, you are correct that Ampio should be trading at much higher prices. There is only one reason Ampio is selling so cheap and I will say it for the hundredth time . . . there is no major baker endorsing the stock today. Very few investors know Fordham or Aegis. If a major banker was endorsing Ampio's shares today, the market cap would be between 1 to 2 billion that puts the price at between $25 to $50. I have done many comps and this is just the simple fact.
Hang in there and be patient. Today's conference was the best ever and clearly demonstrates the explosiveness of Ampio that is within days or weeks . . . not several months and certainly not years.
I was wondering the same thing why hasn't this stock begun to reflect its true value, which essentially encourages the shorts. my fear is that it would take very little to tank this stock based on how little its potential is reflected in the current share price. GLTA. bought another 1000 shares @$4.80 yesterday